{
  "resourceType": "Bundle",
  "id": "HighRiskReferral_eve-geneticriskpop__act-HighRiskReferral",
  "type": "collection",
  "entry": [
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/CarePlan/479",
      "resource": {
        "resourceType": "CarePlan",
        "id": "479",
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-HighRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "created": "2024-12-10T00:00:00.0Z",
        "activity": [
          {
            "reference": {
              "reference": "RequestGroup/480"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/RequestGroup/480",
      "resource": {
        "resourceType": "RequestGroup",
        "id": "480",
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-HighRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "action": [
          {
            "id": "HighRiskReferralGenetic",
            "title": "Referral for high risk breast specialty evaluation",
            "description": "Consider referral to breast specialist to discuss primary risk reduction interventions.\n\nThese may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with a genetic marker or syndrome associated with increased risk of breast cancer, may derive more benefit than harm from risk-reducing medications.",
            "documentation": [
              {
                "type": "citation",
                "label": "USPSTF",
                "display": "Breast Cancer: Medication Use to Reduce Risk",
                "citation": "US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857â€“867.",
                "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction"
              }
            ],
            "resource": {
              "reference": "ServiceRequest/481"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/ServiceRequest/481",
      "resource": {
        "id": "481",
        "resourceType": "ServiceRequest",
        "status": "option",
        "basedOn": [
          {
            "reference": "http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest"
          }
        ],
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "intent": "proposal",
        "code": {
          "coding": [
            {
              "code": "highriskreferral",
              "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/plan-definition-action-code-system",
              "display": "High risk referral"
            }
          ]
        },
        "reasonCode": [
          {
            "coding": [
              {
                "code": "highfamilialrisk",
                "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/screening-observation-code-system",
                "display": "High familial risk"
              }
            ]
          }
        ]
      }
    }
  ]
}